e-learning
resources
Milan 2017
Sunday, 10.09.2017
Novel mechanisms and treatments for asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Molecular evidence of Group 1 innate lymphoid cell activation in the U-BIOPRED cohort
S. Pavlidis (London, United Kingdom)
Source:
International Congress 2017 – Novel mechanisms and treatments for asthma
Session:
Novel mechanisms and treatments for asthma
Session type:
Oral Presentation
Number:
278
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Pavlidis (London, United Kingdom). Molecular evidence of Group 1 innate lymphoid cell activation in the U-BIOPRED cohort. 278
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Profibrotic function of pulmonary group 2 innate lymphoid cells is controlled by regnase-1
Source: Eur Respir J, 57 (3) 2000018; 10.1183/13993003.00018-2020
Year: 2021
Epigenetic control of antiviral and innate immune response following viral infection in a lung epithelial model
Source: Annual Congress 2013 –New insights into epigenetic mechanisms in the lung
Year: 2013
The role of IL-17 producing NK cells and other innate immune cells in poly(I:C) triggered exacerbation of experimental asthma
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016
Central role for phosphoinositide-3-kinase gamma/delta dependent signalling in eosinophilic pulmonary inflammation driven by innate lymphoid cells
Source: International Congress 2017 – Therapeutic approaches in lung disease
Year: 2017
Human mast cells and type 2 innate lymphoid cells activate gene expression and mucus composition in human bronchial epithelial cells via IL-13
Source: International Congress 2014 – Mechanistic studies of the airway epithelium
Year: 2014
Dysregulation of type 2 innate lymphoid cells and Th2 cells impairs pollutant-induced allergic airway responses
Source: International Congress 2016 – Immune responses in the lung
Year: 2016
Presentation by an expert: Innate lymphoid cells: Development, lineage and function
Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease
Year: 2013
Identification and characterisation of isolated human lung dendritic cells (DCs)
Source: Annual Congress 2006 - Cellular immunology in asthma pathogenesis
Year: 2006
Role of the immunoregulatory microRNA miR-146a in the innate immune response to rhinovirus infection
Source: Annual Congress 2013 –Viral infections: what is new?
Year: 2013
Evidence for cell mediated immune dysfunction in the COPD lung: The role of cytotoxic CD4+ T cells
Source: International Congress 2015 – Viral infections: basic research and clinical perspective
Year: 2015
Signalling and transcriptional regulation in inflammatory and immune cells: importance in lung biology and disease
Source: Eur Respir J 2005; 26: 762-763
Year: 2005
Infectious Human Rhinovirus persists in in vitro human nasal epithelial cells with waning induction of corresponding innate immune signatures activation
Source: International Congress 2019 – Mechanisms underlying respiratory infection
Year: 2019
Immunoglobulin-like transcripts 3 (ILT3) expression in human lung adenocarcinoma as a novel regulator of intratumoral lymphoid follicle formation
Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer
Year: 2015
Time course relationships of Type 1 and 2 inflammatory and innate immune pathways during Human Rhinovirus (HRV) infection in subjects with asthma
Source: International Congress 2018 – Asthma analysis
Year: 2018
Complex alterations of lung dendritic cell subsets across distinct asthma phenotypes
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015
Type two innate lymphoid cells (ILC2s) in the blood of children with acute asthma
Source: International Congress 2017 – Diagnostic tools in paediatric asthma
Year: 2017
Nociceptin modulates the inflammatory immune microenvironment in a conventional murine model of asthma
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Year: 2015
Association between T-regulatory cells blood content and Th2 cells activity in asthma
Source: Annual Congress 2013 –Asthma: new mechanisms and markers
Year: 2013
Eotaxin-3 exerts innate host defense activities that are modulated by mast cell proteases
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept